|
Autoantibodies Present in Chronic Hepatitis
C and Chronic Hepatitis B Viral Infections
| table 2. Incidence
of Antibodies to Undefined Peptides Among HCV and HBV Patients |
|
| Peptide (kd) |
HCV Patients (%) (n = 24) |
HBV Patients (%) (n = 24) |
Controls (%) (n = 40) |
|
| 180 |
0 |
0 |
1 (3%) |
| p160 |
1 (4) |
1 (4%) |
0 |
| p155 |
0 |
0 |
1 (3%) |
| p150 |
4 (17) |
7 (29) |
0 |
| p145 |
9 (38) |
7 (29) |
1 (3%) |
| p140 |
3 (13) |
1 (4) |
1 (3%) |
| p135 |
8 (33) |
11 (46) |
0 |
| p130 |
0 |
0 |
3 (9%) |
| p125 |
11 (46) |
12 (50) |
0 |
| p120 |
1 (4) |
2 (8) |
1 (3%) |
| p115 |
8 (33) |
14 (58) |
0 |
| p110 |
2 (8) |
7 (29) |
2 (6%) |
| p108 |
4 (17) |
7 (29) |
0 |
| p100 |
18 (75) |
15 (63) |
1 (3%) |
| p95 |
7 (29) |
14 (58) |
2 (6%) |
| p72 |
1 (4) |
1 (4) |
0 |
| p64 |
14 (58) |
16 (67) |
0 |
| p56 |
13 (54) |
10 (42) |
0 |
| p48 |
13 (54) |
9 (38) |
0 |
| p45 |
8 (33) |
8 (33) |
0 |
| p30 |
7 (29) |
18 (75) |
0 |
|
|
Abbreviations: HCV, hepatitis C virus; HBV, hepatitis
B virus.
|
|
Return To Article
|
